03347.HK
Hangzhou Tigermed Consulting Co., Ltd.
HKSE · Healthcare · Medical - Diagnostics & Research · CN
HKD 39.70
−0.25%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 7.3B | 6.8B | 6.6B | 7.4B | 7.1B |
| Cost of Revenue | 5.4B | 5.0B | 4.4B | 4.5B | 4.3B |
| Gross Profit | 1.9B | 1.9B | 2.2B | 2.8B | 2.8B |
| Operating Expenses | |||||
| R&D Expense | 267.5M | 257.6M | 238.4M | 261.6M | 234.6M |
| SG&A Expense | 320.8M | 322.2M | 349.3M | 306.7M | 406.0M |
| General & Admin Expense | 94.1M | 271.7M | 300.5M | 259.9M | 256.1M |
| Selling & Marketing Expense | (15.2M) | 50.5M | 48.7M | 46.8M | 149.9M |
| Other Expenses | 716.5M | 283.9M | 990.0M | (206.7M) | 357.1M |
| Total Operating Expenses | 1.3B | 863.8M | 1.6B | 361.6M | 997.7M |
| Cost and Expenses | 6.7B | 5.8B | 5.9B | 4.9B | 5.3B |
| Operating Income (EBIT) | 1.2B | 1.0B | 664.4M | 2.5B | 2.6B |
| Non-Operating | |||||
| Interest Income | 243.5M | 15.1M | 90.2M | 229.8M | 227.3M |
| Interest Expense | 78.3M | 90.6M | 141.2M | 119.9M | 83.2M |
| Net Interest Income | 165.2M | (75.4M) | (56.1M) | 105.7M | 138.0M |
| Other Non-Op Income/Expense | (711.7M) | (6.2M) | 42.5K | 1.6M | 3.0M |
| Non-Operating Income (excl Interest) | (1.9B) | (84.4M) | (141.3M) | (121.5M) | (86.2M) |
| EBT (Pre-Tax Income) | 482.1M | 1.0B | 664.5M | 2.5B | 2.6B |
| Income Tax Expense | 223.4M | 198.2M | 216.6M | 338.6M | 313.7M |
| Bottom Line | |||||
| Net Income | 93.2M | 887.9M | 405.1M | 2.0B | 2.0B |
| Earnings from Cont. Ops | 258.7M | 805.1M | 447.8M | 2.1B | 2.3B |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 93.2M | 887.9M | 405.1M | 2.0B | 2.0B |
| Per Share | |||||
| Basic EPS | HK$0.10 | HK$1.03 | HK$0.47 | HK$2.34 | HK$2.32 |
| Diluted EPS | HK$0.10 | HK$1.03 | HK$0.47 | HK$2.34 | HK$2.32 |
| Revenue Per Share | HK$8.71 | HK$7.94 | HK$7.63 | HK$8.54 | HK$8.19 |
| Shares | |||||
| Basic Shares Outstanding | 836.4M | 861.0M | 864.9M | 864.9M | 864.7M |
| Diluted Shares Outstanding | 836.4M | 861.0M | 864.9M | 864.9M | 864.9M |
| Profitability Metrics | |||||
| EBITDA | 1.8B | 1.4B | 1.1B | 2.9B | 2.9B |
| D&A | 191.3M | 326.7M | 324.1M | 305.7M | 264.7M |
| EBIT | 1.7B | 1.1B | 805.7M | 2.6B | 2.7B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026